Tubulin‐Based Microtentacles Aid in Heterotypic Clustering of Neutrophil‐Differentiated HL‐60 Cells and Breast Tumor Cells
Rattachement africain : us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Circulating tumor cells (CTCs) travel through the vasculature to seed secondary sites and serve as direct precursors of metastatic outgrowth for many solid tumors. Heterotypic cell clusters form between CTCs and white blood cells (WBCs) and recent studies report that a majority of these WBCs are neutrophils in patient and mouse models. The lab discovered that CTCs produce tubulin-based protrusions, microtentacles (McTNs), which promote reattachment, retention in distant sites during metastasis and formation of tumor cell clusters. Neutrophil-CTC clusters help CTCs survive the harsh vascular environment to promote successful metastasis, however, the specific mechanism of this interaction is not fully understood. Utilizing TetherChip technology, it is found that primary and differentiated neutrophils produce McTNs composed of detyrosinated and acetylated α-tubulin and vimentin. Neutrophil McTNs aid in cluster formation, migration, and reattachment, which are suppressed with the tubulin-depolymerizing agent, Vinorelbine. Co-culturing differentiated neutrophils and tumor cells formed heterotypic clusters that enhanced migration. CTC-neutrophil clusters have higher metastatic efficiency, and by demonstrating that neutrophils form McTNs, a new possible mechanism for how neutrophils interact with tumor cells is revealed. These findings further support the idea that developing cluster-disrupting therapies can provide a new targeted strategy to reduce the metastatic potential of cancer cells.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Tubulin‐Based Microtentacles Aid in Heterotypic Clustering of Neutrophil‐Differentiated HL‐60 Cells and Breast Tumor Cells
- Date Crossref
- 18/12/2024
- Éditeur
- Wiley
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
University of Maryland Graduate Program in Molecular Medicine pays non établi dans la noticeUniversité ou école supérieure
-
UNC Lineberger Comprehensive Cancer Center pays non établi dans la noticeÉtablissement de santé
-
United States Department of Veterans Affairs pays non établi dans la noticeOrganisme public
-
VA Maryland Health Care System pays non établi dans la noticeÉtablissement de santé
Graduate Program in Molecular Medicine — University of Maryland, UNC Lineberger Comprehensive Cancer Center et United States Department of Veterans Affairs, avec 1 autre affiliation.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.